Enabling end-to-end process solutions for bottles

Ramona Hintner

October 21, 2021

Table of contents

Show

Have you ever been confronted with the term “end-to-end solutions”? Probably yes, because although it is an approach that was first employed in IT, nowadays it affects almost every industry.

The goal of end-to-end solutions is to make the entire process as safe and efficient as possible from beginning to end. Breaking down to biopharmaceuticals this means filling, freezing/thawing and transporting sensitive drug substances by using a single platform. Considering bottles, only isolated solutions for working within those processes were available. Single Use Support has addressed this problem and accomplished the last missing link of end-to-end bottle solutions by providing bottle assemblies from now on.

What is special about it? The end-to-end process applies independently from bottle manufacturer. Furthermore, it is modular and can be topped off with services such as qualifications, after-sales service and biopharma know-how. 

dsc08198

To cover the entire process from A to Z, the biopharma industry has so far been confronted with bottles from various suppliers. However, if the process involves different providers the risk of incompatibility, product loss or damage caused by human error increases. Single Use Support meets these challenges and revolutionizes not only end-to-end solutions for single-use bags but now also for bottles.

So far, Single Use Support provides the following end-to-end solutions for bottles:

  • Bottle.RoSS: Protect your product
  • Bottle.FILL: Fill and filter your drug substance into bottles
  • RoSS.pFTU: Controlled freezing/thawing of bottles
  • RoSS.ULTF: Temperature-controlled storage to maintain cold chain
  • RoSS.SHIP: Protect your bottles for transportation at sub-zero temperature
Product overview single use bottles

Bottle assemblies for aseptic filling

To counteract the mentioned problems the end-to-end solution for bottles has now been further optimized. Previous products used for filling, freezing/thawing and transporting single-use containers have now been complemented by internally produced bottle assemblies – finally completing the end-to-end process in this area.

The major advantage of end-to-end solutions for bottles is that all process steps are carried out by only using a single platform. Companies in the biopharmaceutical industry are thus able to work flexibly and efficiently. Moreover, they benefit from independence from manufacturer, scale, size, and single-use components.

In addition, Single Use Support filling, freezing and storage platforms can be used not only for single-use bottles, but also for bags as well. By providing hybrid end-to-end process solutions for both primary packagings, Single Use Support achieved another milestone in bioprocessing efficiency. This makes switching from single-use containers to single-use bags or working simultaneously with both much easier. Thus, a positive effect on storage space and costs can be achieved.

Complete innovative process solution

Single Use Support offers an elaborate platform for single-use containers and bags that covers the entire process from filling and filtration to freezing/thawing and shipping. Unlike stand-alone silo platforms, this approach addresses specific manufacturer and laboratory requirements. It is high time to let go of said silo mentality that still dominantes many areas and industries. It is time to increase rationalization processes and to eliminate the risk of product loss.

Ramona Hintner

Marketing Manager

More from Ramona Hintner

Read more about Biopharma

Biopharma

Top 7 pharmaceutical CDMOs in 2024

Progress in the pharmaceutical industry is significantly driven by CDMOs, collaborating with pharma companies. In this article, we will put 7 outstanding CDMOs in the spotlight.

michael-muehlegger

Michael Mühlegger

March 12, 2024

Biopharma

CMO vs. CDMO: What are the differences?

Both CMOs and CDMOs are frequently relied on partners in the pharmaceutical industry. But what sets them apart, where are their strengths, and what do they offer?

michael-muehlegger

Michael Mühlegger

March 12, 2024

Biopharma

Start Pharma 4.0: Examples to Advance Ultra-Cold Storage of Drug Substances

Innovative manufacturers are striving for operational excellence in as many areas of bioprocessing as possible. In return,a standardized and fully automated processes contribute to cost efficiency, patient safety, and sustainability in biomanufacturing. 

Alexander Fuchs | Single Use Support

Alexander Fuchs

September 4, 2023

Biopharma

Navigating GMP Annex 1: How Single-Use Assemblies will Comply

GMP Annex 1 significantly impacts the use of single-use assemblies in fluid management processes within the biopharmaceutical industry. It requires manufacturers and stakeholders to adopt a risk-based approach, implement proper controls, and ensure the integrity and sterility of single-use systems.

1640281789974

David Seifert

June 13, 2023